Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obesity and lipids.

Wendy M Miller1, Katherine E Nori-Janosz, Martin Lillystone

  • 1Department of Internal Medicine, Division of Nutrition and Preventive Medicine, William Beaumont Hospital, 4949 Coolidge, Royal Oak, MI 48073, USA. wmiller@beaumont.edu

Current Cardiology Reports
|November 1, 2005
PubMed
Summary

Obesity, particularly abdominal fat, significantly elevates cardiovascular disease risk by triggering metabolic syndrome. Recognizing obesity-related dyslipidemia, beyond LDL cholesterol, is crucial for comprehensive cardiovascular risk assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart Failure.

The American journal of cardiology·2019
Same author

Class effects of SGLT2 inhibitors on cardiorenal outcomes.

Cardiovascular diabetology·2019
Same author

Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.

Kidney international·2019
Same author

Cardiovascular disease care fragmentation in kidney transplantation: a call for action.

Kidney international·2019
Same author

Impact of Durable Ventricular Assist Device Support on Outcomes of Patients with Congenital Heart Disease Waiting for Heart Transplant.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2019
Same author

First and recurrent events after percutaneous coronary intervention: implications for survival analyses.

Scandinavian cardiovascular journal : SCJ·2019

Area of Science:

  • Cardiology
  • Metabolic Health
  • Obesity Medicine

Background:

  • Obesity is a major contributor to cardiovascular disease (CVD) risk.
  • Abdominal (visceral) adiposity drives metabolic syndrome, including atherogenic dyslipidemia, hypertension, and inflammation.
  • Traditional cholesterol guidelines focus on low-density lipoprotein (LDL), but obesity presents complex lipid profiles.

Purpose of the Study:

  • To highlight the multifaceted cardiovascular risks associated with obesity.
  • To emphasize the role of abdominal adiposity in metabolic syndrome.
  • To underscore the importance of recognizing obesity-related dyslipidemia beyond LDL levels.

Main Methods:

  • Review of mechanisms linking obesity to cardiovascular risk.
  • Analysis of the components of metabolic syndrome driven by visceral adiposity.

Related Experiment Videos

  • Comparison of traditional cholesterol assessment with obesity-specific lipid profiles.

    • Main Results:

    • Abdominal adiposity is a key driver of atherogenic dyslipidemia, hyperinsulinemia, hypertension, and inflammation.
    • Metabolic syndrome, stemming from visceral fat, increases risk for CVD and acute coronary events.
    • Obesity-associated dyslipidemia includes low high-density lipoprotein (HDL), high triglycerides, small, dense LDL, and elevated apolipoprotein B-100.

    Conclusions:

    • Obesity significantly elevates cardiovascular risk through mechanisms centered on abdominal adiposity and metabolic syndrome.
    • Comprehensive cardiovascular risk assessment must account for the dyslipidemia characteristic of obesity, not solely LDL levels.
    • Understanding these factors is vital for effective prevention and management of obesity-related cardiovascular complications.